Long-term low-dose co-trimoxazole in prophylaxis of childhood urinary tract infection: bacteriological aspects
- PMID: 974493
- PMCID: PMC1687375
- DOI: 10.1136/bmj.2.6029.206
Long-term low-dose co-trimoxazole in prophylaxis of childhood urinary tract infection: bacteriological aspects
Abstract
The bacteriological consequences of giving long-term low-dose co-trimoxazole to children to prevent reinfection of the urinary tract were studied. Only six "break-through" infections occurred during 2637 child-months of prophylaxis. The children complied well with treatment. During prophylaxis the number of rectal coliform bacilli recovered was greatly and rapidly reduced, but at least 70% of the surviving coliform organisms remained sensitive to the two components of co-trimoxazole. Changes in sensitivity pattern were evident within a month of starting treatment and the proportion of rectal organisms resistant to sulphonamide or trimethoprim did not increase with time. After stopping co-trimoxazole prophylaxis the number of rectal organisms recoverable returned rapidly to normal, as did their sensitivities to trimethoprim and sulphonamide. Further episodes of urinary tract infection developing after prophylaxis was stopped were caused by organisms sensitive to a wide range of antimicrobial agents, including trimethoprim.
Similar articles
-
Prophylactic co-trimoxazole and trimethoprim in the management of urinary tract infection in children.Pediatr Nephrol. 1988 Jan;2(1):12-7. doi: 10.1007/BF00870372. Pediatr Nephrol. 1988. PMID: 3152984
-
Long-term low-dose co-trimoxazole in prophylaxis of childhood urinary tract infection: clinical aspects.Br Med J. 1976 Jul 24;2(6029):203-6. doi: 10.1136/bmj.2.6029.203. Br Med J. 1976. PMID: 974492 Free PMC article.
-
Trimethoprim-sulfamethoxazole and trimethoprim alone in the prophylaxis of childhood urinary tract infection.Rev Infect Dis. 1982 Mar-Apr;4(2):461-6. doi: 10.1093/clinids/4.2.461. Rev Infect Dis. 1982. PMID: 6981164
-
Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.Drugs. 1982 Dec;24(6):459-518. doi: 10.2165/00003495-198224060-00002. Drugs. 1982. PMID: 6759092 Review. No abstract available.
-
Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.Drugs. 1982 Jun;23(6):405-30. doi: 10.2165/00003495-198223060-00001. Drugs. 1982. PMID: 7049657 Review.
Cited by
-
Prophylactic co-trimoxazole and trimethoprim in the management of urinary tract infection in children.Pediatr Nephrol. 1988 Jan;2(1):12-7. doi: 10.1007/BF00870372. Pediatr Nephrol. 1988. PMID: 3152984
-
Antimicrobial prophylaxis.Arch Dis Child. 1999 Apr;80(4):388-92. doi: 10.1136/adc.80.4.388. Arch Dis Child. 1999. PMID: 10086953 Free PMC article. Review. No abstract available.
-
[Prospective alternating comparisons of the operative and nonoperative treatment of vesico-renal reflux].Klin Wochenschr. 1985 Sep 16;63(18):927-33. doi: 10.1007/BF01738147. Klin Wochenschr. 1985. PMID: 4057920 German.
-
Urinary infections in children 1985.Postgrad Med J. 1985 Oct;61(720):895-905. doi: 10.1136/pgmj.61.720.895. Postgrad Med J. 1985. PMID: 3903717 Free PMC article. Review. No abstract available.
-
Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.Antimicrob Agents Chemother. 1981 Jan;19(1):33-8. doi: 10.1128/AAC.19.1.33. Antimicrob Agents Chemother. 1981. PMID: 7247360 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources